A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients

• Status: Completed
• Trial end date: 2010-07-01

Summary

The purpose of this study is to determine whether nepafenac is safe and effective for reducing the incidence of macular edema following cataract surgery in diabetic retinopathy patients.

• Phase: Phase 2

Details

• Lead Sponsor: Alcon Research
• Treatments: Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Nepafenac; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate